SCHEMBL6617359

SCHEMBL6617359

Fc1cccc(-c2cnc3cc4cn[nH]c4cc3n2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.54
ACHE P22303 1/20 0.54
CDC7 O00311 1/20 0.50
MAPK1 P28482 1/20 0.46
IDO1 P14902 1/20 0.44
PDGFRB P09619 4/20 0.43
AURKB Q96GD4 3/20 0.43
PDGFRA P16234 3/20 0.43
MAP4K4 O95819 3/20 0.43
CLK2 P49760 3/20 0.43
CLK4 Q9HAZ1 3/20 0.43
CDK8 P49336 2/20 0.43
PRKX P51817 2/20 0.43
PRKD3 O94806 1/20 0.43
NTRK1 P04629 1/20 0.43
PRKACA P17612 1/20 0.43
LTK P29376 1/20 0.43
CSNK1A1 P48729 1/20 0.43
NTRK3 Q16288 1/20 0.43
NTRK2 Q16620 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6617279 1.00 BCHE (0.54) BCHEACHECDC7MAPK1IDO1
SCHEMBL6616738 0.85 SMN1; SMN2 (0.58) CDC7MAPK1PDGFRBAURKBMAP4K4
SCHEMBL8112788 0.84 CDC7 (0.50) CDC7MAPK1IDO1PDGFRBAURKB
SCHEMBL6618680 0.84 CDC7 (0.50) CDC7MAPK1IDO1PDGFRBAURKB
SCHEMBL6619870 0.84 BCHE (0.54) BCHEACHEMAPK1IDO1PDGFRB
SCHEMBL6618137 0.84 CDC7 (0.50) CDC7MAPK1IDO1PDGFRBAURKB
SCHEMBL6617130 0.84 BCHE (0.54) BCHEACHEMAPK1IDO1PDGFRB
SCHEMBL6617105 0.84 EGFR (0.47) BCHEACHEMAPK1IDO1PDGFRB
SCHEMBL6616183 0.84 EGFR (0.47) BCHEACHEMAPK1IDO1PDGFRB
SCHEMBL6620057 0.84 CDC7 (0.53) CDC7MAPK1IDO1PRKACAPIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779889-B1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE AVENTIS PHARMA INC (US) 2004-06-23 EP disclosed
EP-0779889-A4 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE POULENC RORER PHARMA (US) 2000-02-23 EP disclosed
EP-0779889-A1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1997-06-25 EP disclosed
WO-1996007658-A1 PYRAZOLO[3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-03-14 WO disclosed
US-5476851-A Administering as therapeutic agents for various disease states which are characterized by uncontrolled cellular proliferation RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1995-12-19 US disclosed